Company Profile
MediciNova Stock Price, News & Analysis
- Ticker:
- MNOV
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
1.36 USD (+2.26%)
Close
Last updated: August 6, 2026
66M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, MNOV closed up 2.26% at $1.36. No new same-company headline was identified in the current news window.
Company overview
Business overview
MediciNova is a biotechnology company with programs in inflammation, fibrosis, and neurological disease. Its story is built around repurposing and selective development rather than broad commercial scale.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, MediciNova sits in specialty biotechnology.
Business Model Characteristics
The company depends on clinical data, pipeline prioritization, and the chance to build value from a narrow set of programs.
Position Within the Biotechnology Landscape
MediciNova is a small-cap biotech name whose valuation depends on a few clinical catalysts.
Future catalysts
MediciNova’s catalysts are its repurposed pipeline assets and any strategic update that clarifies which programs still matter. The company needs a clearer clinical path to regain attention.
Recent news
- 01
- 02
MediciNova CEO Provides Shareholder Update
Source: MediciNova
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of MediciNova (MNOV)?
MediciNova (MNOV) most recently closed at 1.36 USD, a +2.26% move versus the previous session.
What is the market cap of MediciNova (MNOV)?
MediciNova currently has a market capitalization of 66M USD on BioPharmSignal.
What does MediciNova do?
MediciNova is a biotechnology company with programs in inflammation, fibrosis, and neurological disease. Its story is built around repurposing and selective development rather than broad commercial scale.
On which exchange is MNOV stock listed?
MediciNova (MNOV) is associated with NASDAQ, United States, Biopharma.
What is MediciNova?
MediciNova’s catalysts are its repurposed pipeline assets and any strategic update that clarifies which programs still matter.
Which conditions is MediciNova targeting with MediciNova?
MediciNova is associated with inflammatory disease based on its company overview and current catalyst commentary.
How does MediciNova describe recent progress with MediciNova?
MediciNova’s catalysts are its repurposed pipeline assets and any strategic update that clarifies which programs still matter.
What future catalysts are investors watching for MediciNova?
MediciNova’s catalysts are its repurposed pipeline assets and any strategic update that clarifies which programs still matter. The company needs a clearer clinical path to regain attention.